These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23800339)

  • 1. Live-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.
    Bachler BC; Humbert M; Lakhashe SK; Rasmussen RA; Ruprecht RM
    Retrovirology; 2013 Jun; 10():63. PubMed ID: 23800339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel biopanning strategy to identify epitopes associated with vaccine protection.
    Bachler BC; Humbert M; Palikuqi B; Siddappa NB; Lakhashe SK; Rasmussen RA; Ruprecht RM
    J Virol; 2013 Apr; 87(8):4403-16. PubMed ID: 23388727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus.
    Sundling C; O'Dell S; Douagi I; Forsell MN; Mörner A; Loré K; Mascola JR; Wyatt RT; Karlsson Hedestam GB
    J Virol; 2010 Sep; 84(18):9086-95. PubMed ID: 20610729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
    Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Martins MA; Tully DC; Pedreño-Lopez N; von Bredow B; Pauthner MG; Shin YC; Yuan M; Lima NS; Bean DJ; Gonzalez-Nieto L; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Bailey VK; Altman JD; Burton DR; Ejima K; Allison DB; Evans DT; Rakasz EG; Parks CL; Bonaldo MC; Capuano S; Lifson JD; Desrosiers RC; Allen TM; Watkins DI
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
    Derby NR; Kraft Z; Kan E; Crooks ET; Barnett SW; Srivastava IK; Binley JM; Stamatatos L
    J Virol; 2006 Sep; 80(17):8745-62. PubMed ID: 16912322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.
    Cox JH; Ferrari MG; Earl P; Lane JR; Jagodzinski LL; Polonis VR; Kuta EG; Boyer JD; Ratto-Kim S; Eller LA; Pham DT; Hart L; Montefiori D; Ferrari G; Parrish S; Weiner DB; Moss B; Kim JH; Birx D; VanCott TC
    Vaccine; 2012 Feb; 30(10):1830-40. PubMed ID: 22234262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
    Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
    J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.
    Lakhashe SK; Byrareddy SN; Zhou M; Bachler BC; Hemashettar G; Hu SL; Villinger F; Else JG; Stock S; Lee SJ; Vargas-Inchaustegui DA; Cofano EB; Robert-Guroff M; Johnson WE; Polonis VR; Forthal DN; Loret EP; Rasmussen RA; Ruprecht RM
    Vaccine; 2014 Nov; 32(48):6527-36. PubMed ID: 25245933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challenges.
    Rasmussen RA; Ong H; Song R; Chenine AL; Ayash-Rashkovsky M; Hu SL; Polacino P; Else JG; Novembre FJ; Ruprecht RM;
    AIDS; 2007 Sep; 21(14):1841-8. PubMed ID: 17721091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.
    Mörner A; Jansson M; Bunnik EM; Schøller J; Vaughan R; Wang Y; Montefiori DC; Otting N; Bontrop R; Bergmeier LA; Singh M; Wyatt RT; Schuitemaker H; Biberfeld G; Thorstensson R; Lehner T
    J Virol; 2011 Jul; 85(13):6442-52. PubMed ID: 21490092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
    AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
    Xiao P; Zhao J; Patterson LJ; Brocca-Cofano E; Venzon D; Kozlowski PA; Hidajat R; Demberg T; Robert-Guroff M
    J Virol; 2010 Jul; 84(14):7161-73. PubMed ID: 20444898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques.
    Patterson LJ; Beal J; Demberg T; Florese RH; Malkevich N; Venzon D; Aldrich K; Richardson E; Kalyanaraman VS; Kalisz I; Lee EM; Montefiori DC; Robey FA; Robert-Guroff M
    Virology; 2008 May; 374(2):322-37. PubMed ID: 18252262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical studies of human immunodeficiency virus/AIDS vaccines: inverse correlation between avidity of anti-Env antibodies and peak postchallenge viremia.
    Zhao J; Lai L; Amara RR; Montefiori DC; Villinger F; Chennareddi L; Wyatt LS; Moss B; Robinson HL
    J Virol; 2009 May; 83(9):4102-11. PubMed ID: 19224993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
    Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
    J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome.
    Martins MA; Gonzalez-Nieto L; Ricciardi MJ; Bailey VK; Dang CM; Bischof GF; Pedreño-Lopez N; Pauthner MG; Burton DR; Parks CL; Earl P; Moss B; Rakasz EG; Lifson JD; Desrosiers RC; Watkins DI
    J Virol; 2020 Nov; 94(24):. PubMed ID: 33028714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.